Study on the hypercoagulable state in patients with angina and myocardial infarction

Y Hu1, S Song, W Wei

  • 1Institute of Hematology, Tongji Medical University, Wuhan.

Journal of Tongji Medical University = Tong Ji Yi Ke Da Xue Xue Bao
|May 12, 2000
PubMed

Insights

Platelet activation, coagulation, and fibrinolysis markers are elevated in coronary heart disease (CHD), particularly in unstable angina (UA) and acute myocardial infarction (AMI) patients. These findings indicate increased thrombotic activity in advanced stages of CHD.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Biochemistry

Background:

  • Coronary heart disease (CHD) involves complex hemostatic alterations.
  • Platelet activation, coagulation, and fibrinolysis are key components of cardiovascular thrombosis.

Purpose of the Study:

  • To investigate molecular markers of platelet activation, coagulation, and fibrinolysis in different stages of CHD.
  • To differentiate hemostatic profiles between stable angina (SA), unstable angina (UA), and acute myocardial infarction (AMI).

Main Methods:

  • Analysis of platelet granule membrane protein 140 (GMP-140) for platelet activation.
  • Measurement of prothrombin fragment F1 + 2 and fibrinopeptide A (FPA) for coagulation activation.
  • Detection of D-dimer and alpha 2-plasma inhibitor (alpha 2-PI) for fibrinolytic state assessment.

Main Results:

  • Elevated GMP-140 levels in all CHD groups suggest general platelet activation.
  • Significantly higher prothrombin fragment F1 + 2 and FPA levels in UA and AMI compared to SA and controls indicate enhanced coagulation.
  • Increased D-dimer and alpha 2-PI in UA and AMI groups suggest activated fibrinolysis.

Conclusions:

  • Platelet activation is present across CHD spectrum.
  • Coagulation and fibrinolytic systems are significantly activated in unstable angina and acute myocardial infarction.
  • These markers may aid in assessing CHD severity and thrombotic risk.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...